SM
MGNX icon

Sabby Management’s MacroGenics MGNX Stock Holding History

Sabby Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-182
Closed -$489K – 195
2021
Q2 		$489K Hold
182
– – 0.07% 112
2021
Q1 		$580K Buy
+182
New +$4.42K 0.11% 101
2016
Q1 		– Sell
-80
Closed -$248K – 332
2015
Q4 		$248K Buy
+80
New +$2.43K 0.01% 276

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sabby Management's MGNX Position: Q3 2014 in Review

Sabby Management sold out of MacroGenics (MGNX) in Q3 2014, closing a stake of 149,839 shares — an estimated $3.26M sold.

Sabby Management first reported a position in MGNX in Q1 2014 and held it in 2 quarters. The position peaked at $4.19M in Q1 2014. 85 funds tracked by Wall St. Rank hold MGNX as of Q3 2014.

  • Sabby Management reported no remaining MacroGenics position as of Q3 2014 after selling out during the quarter.
  • Sabby Management sold 149,839 MacroGenics shares in Q3 2014, an estimated $3.26M.
  • Sabby Management first reported a position in MacroGenics in Q1 2014 and held it in 2 quarters.
  • Sabby Management's MacroGenics position peaked at $4.19M in Q1 2014.
  • 85 funds tracked by Wall St. Rank held MacroGenics as of Q3 2014.

Based on Sabby Management's 13F filing for Q3 2014, filed 14 Nov 2014.